Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    3.50 (1.43%)
Bid:
249.00
Ask:
251.00
Spread: 2.00 (0.803%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Re Directorate

10 Jun 2019 07:00

RNS Number : 5995B
MJ Gleeson PLC
10 June 2019
 

 

MJ Gleeson plc

(GLE.L)

 

For immediate release

Re Directorate

The Board of MJ Gleeson plc ("Gleeson", "the Group" or "the Company") announces that Jolyon Harrison who joined the Board in July 2010 and was appointed Chief Executive Officer on 1 July 2012, has stepped down from the Board and left the Company with immediate effect.

Following extensive discussions with Mr Harrison regarding his remuneration and succession planning, the Board concluded that it was not possible to find a mutually acceptable basis for Mr Harrison to continue as Chief Executive Officer.

The Board announces that James Thomson will join the Board as Chief Executive Officer on an interim basis with immediate effect. Mr Thomson is formerly Chief Executive of Keepmoat Homes Ltd, a private equity owned housebuilder selling over 4,000 homes a year, and where Mr Thomson remains a non-executive director and shareholder.

The Board is initiating a search process, which will include both internal and external candidates, to identify a long-term CEO appointment.

Gleeson has a very strong management team comprising Stefan Allanson (Chief Financial Officer), Sarah Marsden (Gleeson Homes COO), Bryan Simpson (Gleeson Homes MD) and James Pitt (Gleeson Strategic Land Deputy MD). The Board believes that the Company is very well placed to continue to achieve strong growth in turnover and profits.

The Company is scheduled to issue its next trading update in early July and results for the year ended 30 June 2019 on 16 September 2019.

Meanwhile, the Board re-affirms its previous guidance that it anticipates the Group will deliver a result for the year in line with expectations.

 ENDS

10 June 2019

Notes:

James Thomson was a director of DTZ Holdings plc (DTZ) from 8 August 2011 when he was promoted to Group Finance Director until the operational business of DTZ was sold as a going concern on 4 December 2011 to UGL Ltd. James remained as a Director of the DTZ Holdings plc, the holding company of DTZ, until it went into liquidation in September 2012. DTZ was listed on the London Stock Exchange and was majority owned by Saint George Participations SAS (SGP) with the remaining shares being widely held. In May 2011, DTZ had announced that it was in discussions with SGP about an offer for the whole of DTZ. On 17 October 2011, SGP announced that discussions between it and DTZ had been terminated and confirmed it would not be making an offer for DTZ. On 19 October 2011, DTZ announced the commencement of a formal sale process and a pre-agreed sale of the business in administration was considered necessary in order to sell the business as a going concern. On 4 December 2011, the Court appointed joint administrators of DTZ who then completed a sale of the business and assets of DTZ to a subsidiary of UGL Limited, an Australian listed property services group. DTZ subsequently went into creditors' voluntary liquidation on 2 October 2012, before being dissolved on 22 March 2017. No public criticism by any statutory or regulatory authority (including recognised professional bodies) or disqualification proceedings have been made or brought against James Thomson relating to his directorship of DTZ.

 

No further information is required to be disclosed pursuant to LR 9.6.13 R.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person responsible for arranging the release of this announcement on behalf of the Company is Stefan Allanson, Chief Financial Officer.

LEI: 21380064K7N2W7FD6434

 

Enquiries:

Instinctif Partners

Tel: +44 7771 860938

Mark Garraway

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGUQPQUPBGBB
Date   Source Headline
12th Feb 20254:14 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSResults for the half year ended 31 December 2024
7th Feb 202511:51 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update & Notice of Results
7th Jan 20254:28 pmRNSDirector/PDMR Shareholding
9th Dec 20244:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:50 pmRNSDirector/PDMR Shareholding
26th Nov 20243:34 pmRNSDirector/PDMR Shareholding
15th Nov 20242:08 pmRNSResult of AGM
15th Nov 20247:00 amRNSAGM Trading Update
7th Nov 20242:44 pmRNSDirector/PDMR Shareholding
30th Oct 202410:42 amRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSNotice of AGM
18th Oct 20244:24 pmRNSDirector/PDMR Shareholding
18th Oct 20244:19 pmRNSDirector/PDMR Shareholding
9th Oct 20244:27 pmRNSDirector/PDMR Shareholding
4th Oct 202410:18 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSAudited results for the year ended 30 June 2024
9th Sep 202410:18 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTotal Voting Rights
7th Aug 20249:41 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTotal Voting Rights
23rd Jul 20242:36 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:53 pmRNSStandard form for notification of major holdings
11th Jul 20247:00 amRNSFY2024 Trading Update
8th Jul 20241:34 pmRNSDirector/PDMR Shareholding
8th Jul 20247:00 amRNSNotice of Trading Update
28th Jun 20247:00 amRNSTotal Voting Rights
6th Jun 20242:46 pmRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSAppointment of Joint Corporate Broker
9th May 20249:41 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20243:41 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:28 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:28 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20249:07 amRNSDirector/PDMR Shareholding
20th Mar 20241:45 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20241:04 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
7th Feb 202411:34 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
9th Jan 202410:50 amRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTrading Update & Notice of Results
29th Dec 20237:00 amRNSTotal Voting Rights
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.